Publications by authors named "C Galant"

Claim this Profile
T
TERT promoter mutations are useful to distinguish phyllodes tumours with a fibroadenoma-like morphology from cellular fibroadenomas.
Alex Fortun, Hilde Vernaeve, Anne-France Dekairelle, Ophélie Simon, Tanja Schraepen, Christine Galant

Histopathology· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reproducibility of Equivocal HER2 In Situ Hybridization Groups 3 and 4, and Comparison With HER2 mRNA Expression: The Thin Line Between Amplified and Nonamplified Breast Cancers.
Ximena Baez-Navarro, Julia Riggi, David Zylberberg, Angelique van der Made, Dominique Dubois, Christine Galant

Arch Pathol Lab Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of short-course durvalumab combined with dose-dense EC in the neoadjuvant setting for locally advanced luminal B/HER2(-) or triple-negative breast cancer.
Alix Devaux, Gabriela Beniuga, Paul Delrée, Claire Quaghebeur, Stephanie Henry, Christine Galant

Breast Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint-induced arthritis: a comprehensive single-cohort descriptive analysis from clinical evaluation to histology.
Laurent Meric de Bellefon, Francesco Natalucci, Adrien Nzeusseu Toukap, Tatiana Sokolova, Christine Galant

Front Med (Lausanne)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Histopathological Markers for Upstaging to Invasive Carcinoma after a Biopsy Diagnosis of Ductal Carcinoma in situ of the Breast: A Hypothesis-Generating Systematic Review.
Julia A M Riggi, Ibrahim Kassem, Christine Galant, Carolien H M van Deurzen, Martine Berlière

Pathobiology· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis